A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system's ability to kill melanoma tumors deficient
in the tumor suppressor gene PTEN.
«Identifying targets essential to cell
survival in tumor suppressor genes has long been an investigational goal with the aim of offering cancer - specific vulnerabilities for targeted therapy,» said Ronald DePinho, M.D., professor of Cancer Biology, MD Anderson president, and senior author for the Nature paper.
In back - to - back papers published online July 28 in Science, researchers from the Broad Institute, Dana - Farber Cancer Institute, Johns Hopkins Kimmel Cancer Center, the University of Pittsburgh, and the University of Texas MD Anderson Cancer Center have confirmed genetic abnormalities previously suspected in head and neck cancer, including
defects in the tumor suppressor gene known as p53.
The mutations may be in genes governing some aspect of the immune system but they might also be
in tumor suppressor genes whose job it is to seek out and destroy cancerous cells, genes that control cell division, genes that control normal cell death, and other types as well.
This common genetic heritage is a potential achilles heel of the metastases, however, many of these shared mutations are
in tumor suppressor genes and our approach to therapeutically targeting these needs to be prioritised.
Moreover, many human tumors have highly abnormal numbers of chromosomes (that is, they are aneuploid), with initial chromosomal loss participating in the early steps of the transformation cascade in inherited cancers caused by heterozygous mutation
in tumor suppressor genes and the more widespread aneuploidy characteristic of advance tumors thought to drive acquisition of malignant growth properties.??
The most frequent tumors in human — cancer of the colon, breast, lung, and prostate — all involve mutations
in tumor suppressor genes.